TreeWAS – Variant ID: rs9260973

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E83.1 Disorders of iron metabolism	1.000	0.000	0.000
I83.9 Varicose veins of lower extremities without ulcer or inflammation	1.000	0.000	0.000
G35 Multiple sclerosis	1.000	0.000	0.000
L03.1 Cellulitis of other parts of limb	1.000	0.000	0.000
L40.9 Psoriasis, unspecified	0.000	0.006	0.994
L40 Psoriasis	0.000	0.007	0.993
L40.5 Arthropathic psoriasis	0.000	0.007	0.993
E83 Disorders of mineral metabolism	0.980	0.020	0.000
E70-E90 Metabolic disorders	0.978	0.022	0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.971	0.029	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.967	0.033	0.000
I83 Varicose veins of lower extremities	0.966	0.034	0.000
G35-G37 Demyelinating diseases of the central nervous system	0.964	0.036	0.000
E89.0 Postprocedural hypothyroidism	0.962	0.038	0.000
E00-E07 Disorders of thyroid gland	0.951	0.049	0.000
Chapter VI Diseases of the nervous system	0.944	0.056	0.000
L03 Cellulitis	0.942	0.058	0.000
# Top node	0.939	0.061	0.000
I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified	0.938	0.062	0.000
Chapter XII Diseases of the skin and subcutaneous tissue	0.932	0.068	0.000
L00-L08 Infections of the skin and subcutaneous tissue	0.932	0.068	0.000
Chapter IX Diseases of the circulatory system	0.932	0.068	0.000
E04 Other non-toxic goitre	0.908	0.092	0.000
E80 Disorders of porphyrin and bilirubin metabolism	0.897	0.103	0.000
E03 Other hypothyroidism	0.895	0.105	0.000
G30-G32 Other degenerative diseases of the nervous system	0.880	0.120	0.000
E03.9 Hypothyroidism, unspecified	0.869	0.131	0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.868	0.132	0.000
Chapter XX External causes of morbidity and mortality	0.866	0.134	0.000
E04.2 Non-toxic multinodular goitre	0.864	0.136	0.000
Chapter XXII Codes for special purposes	0.853	0.147	0.000
Q20-Q28 Congenital malformations of the circulatory system	0.850	0.150	0.000
L40.0 Psoriasis vulgaris	0.000	0.157	0.843
I95-I99 Other and unspecified disorders of the circulatory system	0.837	0.163	0.000
Chapter V Mental and behavioural disorders	0.826	0.174	0.000
G00-G09 Inflammatory diseases of the central nervous system	0.821	0.179	0.000
L04 Acute lymphadenitis	0.821	0.179	0.000
I85 Oesophageal varices	0.821	0.179	0.000
L20-L30 Dermatitis and eczema	0.816	0.184	0.000
V40-V49 Car occupant injured in transport accident	0.815	0.185	0.000
G20-G26 Extrapyramidal and movement disorders	0.814	0.186	0.000
I70-I79 Diseases of arteries, arterioles and capillaries	0.809	0.191	0.000
E89.2 Postprocedural hypoparathyroidism	0.806	0.194	0.000
L40-L45 Papulosquamous disorders	0.668	0.202	0.129
E04.9 Non-toxic goitre, unspecified	0.794	0.206	0.000
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.790	0.210	0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.790	0.210	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.788	0.212	0.000
E65-E68 Obesity and other hyperalimentation	0.786	0.214	0.000
E84 Cystic fibrosis	0.786	0.214	0.000
I99 Other and unspecified disorders of circulatory system	0.785	0.215	0.000
I83.0 Varicose veins of lower extremities with ulcer	0.782	0.218	0.000
Q25 Congenital malformations of great arteries	0.777	0.223	0.000
E80.1 Porphyria cutanea tarda	0.777	0.223	0.000
Q23 Congenital malformations of aortic and mitral valves	0.769	0.231	0.000
I98 Other disorders of circulatory system in diseases classified elsewhere	0.765	0.235	0.000
X40-X49 Accidental poisoning by and exposure to noxious substances	0.764	0.236	0.000
V49 Car occupant injured in other and unspecified transport accidents	0.754	0.246	0.000
E89.4 Postprocedural ovarian failure	0.753	0.247	0.000
G30 Alzheimer's disease	0.753	0.247	0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.751	0.249	0.000
F00-F09 Organic, including symptomatic, mental disorders	0.749	0.251	0.000
E06 Thyroiditis	0.748	0.252	0.000
E73 Lactose intolerance	0.747	0.253	0.000
E80.4 Gilbert's syndrome	0.745	0.255	0.000
E40-E46 Malnutrition	0.745	0.255	0.000
Q24 Other congenital malformations of heart	0.744	0.256	0.000
I88 Nonspecific lymphadenitis	0.743	0.257	0.000
G25 Other extrapyramidal and movement disorders	0.743	0.257	0.000
E04.0 Non-toxic diffuse goitre	0.740	0.260	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.740	0.260	0.000
I85.9 Oesophageal varices without bleeding	0.738	0.262	0.000
I89 Other non-infective disorders of lymphatic vessels and lymph nodes	0.737	0.263	0.000
V10-V19 Pedal cyclist injured in transport accident	0.736	0.264	0.000
Q80-Q89 Other congenital malformations	0.733	0.267	0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.732	0.268	0.000
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.730	0.270	0.000
I70 Atherosclerosis	0.728	0.272	0.000
I60-I69 Cerebrovascular diseases	0.727	0.273	0.000
I72 Other aneurysm	0.727	0.273	0.000
E65 Localised adiposity	0.721	0.279	0.000
L40.4 Guttate psoriasis	0.000	0.288	0.712
L40.3 Pustulosis palmaris et plantaris	0.000	0.288	0.712
L40.2 Acrodermatitis continua	0.000	0.288	0.712
L40.1 Generalised pustular psoriasis	0.000	0.288	0.712
G31.9 Degenerative disease of nervous system, unspecified	0.709	0.291	0.000
G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere	0.709	0.291	0.000
W00-W19 Falls	0.708	0.292	0.000
L40.8 Other psoriasis	0.000	0.293	0.707
G06 Intracranial and intraspinal abscess and granuloma	0.707	0.293	0.000
F10 Mental and behavioural disorders due to use of alcohol	0.704	0.296	0.000
E83.9 Disorder of mineral metabolism, unspecified	0.702	0.297	0.000
E83.8 Other disorders of mineral metabolism	0.702	0.297	0.000
E83.2 Disorders of zinc metabolism	0.702	0.297	0.000
E83.0 Disorders of copper metabolism	0.702	0.297	0.000
E79 Disorders of purine and pyrimidine metabolism	0.701	0.299	0.000
E77 Disorders of glycoprotein metabolism	0.701	0.299	0.000
E76 Disorders of glycosaminoglycan metabolism	0.701	0.299	0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.701	0.299	0.000
E72 Other disorders of amino-acid metabolism	0.701	0.299	0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.701	0.299	0.000
E70 Disorders of aromatic amino-acid metabolism	0.701	0.299	0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.701	0.299	0.000
Q23.1 Congenital insufficiency of aortic valve	0.699	0.301	0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.696	0.304	0.000
E89.8 Other postprocedural endocrine and metabolic disorders	0.696	0.304	0.000
E89.5 Postprocedural testicular hypofunction	0.696	0.304	0.000
E89.1 Postprocedural hypoinsulinaemia	0.696	0.304	0.000
L04.1 Acute lymphadenitis of trunk	0.693	0.307	0.000
I83.2 Varicose veins of lower extremities with both ulcer and inflammation	0.693	0.307	0.000
E05 Thyrotoxicosis [hyperthyroidism]	0.692	0.308	0.000
F10.1 Harmful use	0.692	0.308	0.000
G36 Other acute disseminated demyelination	0.691	0.308	0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.691	0.309	0.000
I98.2 Oesophageal varices in diseases classified elsewhere	0.691	0.309	0.000
L10-L14 Bullous disorders	0.690	0.310	0.000
L60-L75 Disorders of skin appendages	0.689	0.311	0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.686	0.313	0.000
L29 Pruritus	0.686	0.314	0.000
I05-I09 Chronic rheumatic heart diseases	0.686	0.314	0.000
L03.8 Cellulitis of other sites	0.685	0.314	0.000
I70.2 Atherosclerosis of arteries of the extremities	0.684	0.316	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.682	0.318	0.000
E00 Congenital iodine-deficiency syndrome	0.682	0.318	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.682	0.318	0.000
G31.2 Degeneration of nervous system due to alcohol	0.681	0.319	0.000
Y44 Agents primarily affecting blood constituents	0.681	0.319	0.000
E88 Other metabolic disorders	0.678	0.322	0.000
I87 Other disorders of veins	0.678	0.322	0.000
V43 Car occupant injured in collision with car, pick-up truck or van	0.677	0.323	0.000
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction	0.677	0.323	0.000
Q25.1 Coarctation of aorta	0.676	0.324	0.000
I71 Aortic aneurysm and dissection	0.676	0.324	0.000
Q24.8 Other specified congenital malformations of heart	0.675	0.325	0.000
Chapter XVI Certain conditions originating in the perinatal period	0.673	0.327	0.000
F60-F69 Disorders of adult personality and behaviour	0.670	0.330	0.000
E80.2 Other porphyria	0.669	0.330	0.000
L01 Impetigo	0.668	0.332	0.000
L00 Staphylococcal scalded skin syndrome	0.668	0.332	0.000
I00-I02 Acute rheumatic fever	0.668	0.332	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.668	0.332	0.000
E80.6 Other disorders of bilirubin metabolism	0.667	0.333	0.000
G25.8 Other specified extrapyramidal and movement disorders	0.666	0.334	0.000
L04.9 Acute lymphadenitis, unspecified	0.666	0.334	0.000
Y45.2 Propionic acid derivatives	0.663	0.337	0.000
X50-X57 Overexertion, travel and privation	0.661	0.339	0.000
F01 Vascular dementia	0.659	0.341	0.000
E74 Other disorders of carbohydrate metabolism	0.658	0.342	0.000
I69 Sequelae of cerebrovascular disease	0.657	0.343	0.000
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.655	0.345	0.000
G80-G83 Cerebral palsy and other paralytic syndromes	0.654	0.346	0.000
V80-V89 Other land transport accidents	0.654	0.346	0.000
Y45.0 Opioids and related analgesics	0.654	0.346	0.000
I89.0 Lymphoedema, not elsewhere classified	0.653	0.347	0.000
I80 Phlebitis and thrombophlebitis	0.653	0.347	0.000
X00-X09 Exposure to smoke, fire and flames	0.653	0.347	0.000
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.653	0.347	0.000
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.652	0.348	0.000
L03.3 Cellulitis of trunk	0.651	0.349	0.000
E04.8 Other specified non-toxic goitre	0.651	0.349	0.000
V18 Pedal cyclist injured in noncollision transport accident	0.651	0.349	0.000
V49.9 Car occupant [any] injured in unspecified traffic accident	0.650	0.350	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.650	0.350	0.000
G90-G99 Other disorders of the nervous system	0.650	0.350	0.000
E84.9 Cystic fibrosis, unspecified	0.649	0.351	0.000
X60-X84 Intentional self-harm	0.648	0.352	0.000
V49.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident	0.647	0.353	0.000
W75-W84 Other accidental threats to breathing	0.645	0.355	0.000
G30.0 Alzheimer's disease with early onset	0.644	0.356	0.000
V20-V29 Motorcycle rider injured in transport accident	0.644	0.356	0.000
L20 Atopic dermatitis	0.643	0.357	0.000
E80.7 Disorder of bilirubin metabolism, unspecified	0.643	0.357	0.000
E80.5 Crigler-Najjar syndrome	0.643	0.357	0.000
E80.3 Defects of catalase and peroxydase	0.643	0.357	0.000
E80.0 Hereditary erythropoietic porphyria	0.643	0.357	0.000
E03.5 Myxoedema coma	0.642	0.358	0.000
E03.4 Atrophy of thyroid (acquired)	0.642	0.358	0.000
E03.3 Postinfectious hypothyroidism	0.642	0.358	0.000
E03.1 Congenital hypothyroidism without goitre	0.642	0.358	0.000
E03.0 Congenital hypothyroidism with diffuse goitre	0.642	0.358	0.000
V70-V79 Bus occupant injured in transport accident	0.641	0.359	0.000
U80 Agent resistant to penicillin and related antibiotics	0.639	0.361	0.000
E06.3 Autoimmune thyroiditis	0.638	0.362	0.000
L71 Rosacea	0.637	0.363	0.000
Q25.0 Patent ductus arteriosus	0.637	0.363	0.000
E20-E35 Disorders of other endocrine glands	0.637	0.363	0.000
I72.3 Aneurysm of iliac artery	0.636	0.364	0.000
E83.3 Disorders of phosphorus metabolism	0.635	0.365	0.000
V48 Car occupant injured in noncollision transport accident	0.634	0.366	0.000
W50-W64 Exposure to animate mechanical forces	0.633	0.367	0.000
Q89 Other congenital malformations, not elsewhere classified	0.633	0.367	0.000
G32 Other degenerative disorders of nervous system in diseases classified elsewhere	0.631	0.369	0.000
L30 Other dermatitis	0.630	0.370	0.000
L21 Seborrhoeic dermatitis	0.630	0.370	0.000
G05.1 Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere	0.629	0.371	0.000
L28 Lichen simplex chronicus and prurigo	0.629	0.371	0.000
U88 Agent resistant to multiple antibiotics	0.628	0.371	0.000
V01-V09 Pedestrian injured in transport accident	0.628	0.372	0.000
I65.0 Occlusion and stenosis of vertebral artery	0.626	0.374	0.000
L03.9 Cellulitis, unspecified	0.624	0.376	0.000
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.623	0.377	0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.622	0.378	0.000
Q35-Q37 Cleft lip and cleft palate	0.622	0.378	0.000
Q30-Q34 Congenital malformations of the respiratory system	0.622	0.378	0.000
L42 Pityriasis rosea	0.550	0.378	0.071
F80-F89 Disorders of psychological development	0.622	0.378	0.000
Y35-Y36 Legal intervention and operations of war	0.621	0.379	0.000
Y10-Y34 Event of undetermined intent	0.621	0.379	0.000
X85-X99 Assault	0.621	0.379	0.000
X30-X39 Exposure to forces of nature	0.621	0.379	0.000
W65-W74 Accidental drowning and submersion	0.621	0.379	0.000
V98-V99 Other and unspecified transport accidents	0.621	0.379	0.000
V95-V97 Air and space transport accidents	0.621	0.379	0.000
V90-V94 Water transport accidents	0.621	0.379	0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.621	0.379	0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.621	0.379	0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.621	0.379	0.000
Y48 Anaesthetics and therapeutic gases	0.621	0.379	0.000
G37 Other demyelinating diseases of central nervous system	0.620	0.380	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.619	0.380	0.000
I83.1 Varicose veins of lower extremities with inflammation	0.617	0.383	0.000
I98.3 Oesophageal varices with bleeding in diseases classified elsewhere	0.615	0.385	0.000
F10.5 Psychotic disorder	0.614	0.386	0.000
G06.1 Intraspinal abscess and granuloma	0.613	0.387	0.000
X42 Accidental poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.612	0.387	0.000
X49 Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances	0.611	0.389	0.000
I79 Disorders of arteries, arterioles and capillaries in diseases classified elsewhere	0.611	0.389	0.000
Q28 Other congenital malformations of circulatory system	0.610	0.390	0.000
Q26 Congenital malformations of great veins	0.610	0.390	0.000
Q22 Congenital malformations of pulmonary and tricuspid valves	0.610	0.390	0.000
Q20 Congenital malformations of cardiac chambers and connexions	0.610	0.390	0.000
W06 Fall involving bed	0.609	0.391	0.000
G31.0 Circumscribed brain atrophy	0.607	0.393	0.000
G03 Meningitis due to other and unspecified causes	0.606	0.394	0.000
G24 Dystonia	0.605	0.395	0.000
L04.0 Acute lymphadenitis of face, head and neck	0.604	0.396	0.000
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.603	0.397	0.000
I80.0 Phlebitis and thrombophlebitis of superficial vessels of lower extremities	0.602	0.398	0.000
W01 Fall on same level from slipping, tripping and stumbling	0.602	0.398	0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.601	0.399	0.000
G04 Encephalitis, myelitis and encephalomyelitis	0.600	0.400	0.000
F12 Mental and behavioural disorders due to use of cannabinoids	0.599	0.401	0.000
Q25.6 Stenosis of pulmonary artery	0.598	0.402	0.000
G25.9 Extrapyramidal and movement disorder, unspecified	0.597	0.403	0.000
I61 Intracerebral haemorrhage	0.597	0.403	0.000
L23 Allergic contact dermatitis	0.597	0.403	0.000
I88.0 Nonspecific mesenteric lymphadenitis	0.596	0.404	0.000
V18.2 Unspecified pedal cyclist injured in nontraffic accident	0.595	0.405	0.000
F01.9 Vascular dementia, unspecified	0.595	0.405	0.000
I07 Rheumatic tricuspid valve diseases	0.595	0.405	0.000
E85 Amyloidosis	0.594	0.406	0.000
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.592	0.408	0.000
Y44.2 Anticoagulants	0.592	0.408	0.000
G30.8 Other Alzheimer's disease	0.591	0.409	0.000
Q21 Congenital malformations of cardiac septa	0.591	0.409	0.000
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.590	0.410	0.000
Q27 Other congenital malformations of peripheral vascular system	0.589	0.411	0.000
G07 Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere	0.589	0.411	0.000
L04.8 Acute lymphadenitis of other sites	0.589	0.411	0.000
L04.3 Acute lymphadenitis of lower limb	0.589	0.411	0.000
L04.2 Acute lymphadenitis of upper limb	0.589	0.411	0.000
Q23.0 Congenital stenosis of aortic valve	0.588	0.412	0.000
X20-X29 Contact with venomous animals and plants	0.588	0.412	0.000
I85.0 Oesophageal varices with bleeding	0.588	0.412	0.000
X10-X19 Contact with heat and hot substances	0.588	0.412	0.000
G00 Bacterial meningitis, not elsewhere classified	0.586	0.413	0.000
Y40 Systemic antibiotics	0.586	0.414	0.000
L24 Irritant contact dermatitis	0.585	0.414	0.000
L26 Exfoliative dermatitis	0.585	0.414	0.000
L22 Diaper [napkin] dermatitis	0.585	0.414	0.000
E46 Unspecified protein-energy malnutrition	0.585	0.415	0.000
X44 Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.585	0.415	0.000
V47 Car occupant injured in collision with fixed or stationary object	0.585	0.415	0.000
V46 Car occupant injured in collision with other nonmotor vehicle	0.585	0.415	0.000
V45 Car occupant injured in collision with railway train or railway vehicle	0.585	0.415	0.000
V42 Car occupant injured in collision with two- or three-wheeled motor vehicle	0.585	0.415	0.000
V41 Car occupant injured in collision with pedal cycle	0.585	0.415	0.000
V40 Car occupant injured in collision with pedestrian or animal	0.585	0.415	0.000
E27 Other disorders of adrenal gland	0.584	0.416	0.000
G23 Other degenerative diseases of basal ganglia	0.584	0.416	0.000
G21 Secondary Parkinsonism	0.584	0.416	0.000
G26 Extrapyramidal and movement disorders in diseases classified elsewhere	0.584	0.416	0.000
G22 Parkinsonism in diseases classified elsewhere	0.584	0.416	0.000
W10 Fall on and from stairs and steps	0.584	0.416	0.000
E73.9 Lactose intolerance, unspecified	0.581	0.419	0.000
U80.8 Agent resistant to other penicillin-related antibiotic	0.581	0.419	0.000
F70-F79 Mental retardation	0.579	0.421	0.000
Y00-Y09 Assault	0.579	0.421	0.000
F00 Dementia in Alzheimer's disease	0.579	0.421	0.000
V43.9 Unspecified car occupant injured in traffic accident	0.579	0.421	0.000
F99-F99 Unspecified mental disorder	0.577	0.423	0.000
I82 Other venous embolism and thrombosis	0.577	0.423	0.000
E50-E64 Other nutritional deficiencies	0.576	0.424	0.000
F07.0 Organic personality disorder	0.575	0.425	0.000
X47 Accidental poisoning by and exposure to other gases and vapours	0.575	0.425	0.000
L29.8 Other pruritus	0.575	0.425	0.000
Y45.5 4-Aminophenol derivatives	0.574	0.426	0.000
Q82 Other congenital malformations of skin	0.574	0.426	0.000
G08 Intracranial and intraspinal phlebitis and thrombophlebitis	0.574	0.426	0.000
I72.8 Aneurysm of other specified arteries	0.574	0.426	0.000
G70-G73 Diseases of myoneural junction and muscle	0.573	0.427	0.000
V49.5 Passenger injured in collision with other and unspecified motor vehicles in traffic accident	0.572	0.428	0.000
L44 Other papulosquamous disorders	0.479	0.428	0.093
L41 Parapsoriasis	0.479	0.428	0.093
L45 Papulosquamous disorders in diseases classified elsewhere	0.479	0.428	0.093
I72.4 Aneurysm of artery of lower extremity	0.572	0.428	0.000
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.570	0.430	0.000
L03.2 Cellulitis of face	0.570	0.430	0.000
Y59 Other and unspecified vaccines and biological substances	0.569	0.431	0.000
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.568	0.432	0.000
F50 Eating disorders	0.568	0.432	0.000
Y45.8 Other analgesics and antipyretics	0.567	0.433	0.000
G31.1 Senile degeneration of brain, not elsewhere classified	0.567	0.433	0.000
Q87 Other specified congenital malformation syndromes affecting multiple systems	0.566	0.434	0.000
Y79 Orthopaedic devices associated with adverse incidents	0.566	0.434	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.565	0.435	0.000
Y58 Bacterial vaccines	0.565	0.435	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.565	0.435	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.565	0.435	0.000
W18 Other fall on same level	0.564	0.435	0.000
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.564	0.436	0.000
E67 Other hyperalimentation	0.564	0.436	0.000
E68 Sequelae of hyperalimentation	0.564	0.436	0.000
E84.8 Cystic fibrosis with other manifestations	0.564	0.436	0.000
E84.1 Cystic fibrosis with intestinal manifestations	0.564	0.436	0.000
E84.0 Cystic fibrosis with pulmonary manifestations	0.564	0.436	0.000
F11 Mental and behavioural disorders due to use of opioids	0.563	0.436	0.000
L29.2 Pruritus vulvae	0.563	0.437	0.000
Q89.2 Congenital malformations of other endocrine glands	0.561	0.439	0.000
G06.2 Extradural and subdural abscess, unspecified	0.558	0.442	0.000
G09 Sequelae of inflammatory diseases of central nervous system	0.558	0.442	0.000
L43 Lichen planus	0.501	0.442	0.057
I69.1 Sequelae of intracerebral haemorrhage	0.557	0.443	0.000
Q25.9 Congenital malformation of great arteries, unspecified	0.557	0.443	0.000
Q25.8 Other congenital malformations of great arteries	0.557	0.443	0.000
Q25.7 Other congenital malformations of pulmonary artery	0.557	0.443	0.000
Q25.5 Atresia of pulmonary artery	0.557	0.443	0.000
Q25.4 Other congenital malformations of aorta	0.557	0.443	0.000
Q25.3 Stenosis of aorta	0.557	0.443	0.000
Q25.2 Atresia of aorta	0.557	0.443	0.000
V28 Motorcycle rider injured in noncollision transport accident	0.557	0.443	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.556	0.444	0.000
G02 Meningitis in other infectious and parasitic diseases classified elsewhere	0.556	0.444	0.000
F02 Dementia in other diseases classified elsewhere	0.555	0.445	0.000
L71.9 Rosacea, unspecified	0.555	0.445	0.000
L71.1 Rhinophyma	0.555	0.445	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.555	0.445	0.000
E27.1 Primary adrenocortical insufficiency	0.554	0.446	0.000
W15 Fall from cliff	0.553	0.447	0.000
Q00-Q07 Congenital malformations of the nervous system	0.553	0.447	0.000
G25.3 Myoclonus	0.553	0.447	0.000
I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified	0.552	0.448	0.000
Q23.9 Congenital malformation of aortic and mitral valves, unspecified	0.551	0.449	0.000
Q23.8 Other congenital malformations of aortic and mitral valves	0.551	0.449	0.000
Q23.4 Hypoplastic left heart syndrome	0.551	0.449	0.000
Q23.3 Congenital mitral insufficiency	0.551	0.449	0.000
Q23.2 Congenital mitral stenosis	0.551	0.449	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.551	0.449	0.000
F69 Unspecified disorder of adult personality and behaviour	0.550	0.449	0.000
U89 Agent resistant to other and unspecified antibiotics	0.550	0.449	0.000
Y54.4 Loop [high-ceiling] diuretics	0.549	0.450	0.000
Y54.5 Other diuretics	0.549	0.451	0.000
I98.8 Other specified disorders of circulatory system in diseases classified elsewhere	0.549	0.451	0.000
I98.1 Cardiovascular disorders in other infectious and parasitic diseases classified elsewhere	0.549	0.451	0.000
I98.0 Cardiovascular syphilis	0.549	0.451	0.000
X48 Accidental poisoning by and exposure to pesticides	0.548	0.452	0.000
X46 Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.548	0.452	0.000
X43 Accidental poisoning by and exposure to other drugs acting on the autonomic nervous system	0.548	0.452	0.000
X40 Accidental poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.548	0.452	0.000
L63 Alopecia areata	0.548	0.452	0.000
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction	0.547	0.453	0.000
Y54.7 Agents affecting calcification	0.547	0.453	0.000
E34 Other endocrine disorders	0.547	0.453	0.000
I86 Varicose veins of other sites	0.547	0.453	0.000
E88.1 Lipodystrophy, not elsewhere classified	0.546	0.454	0.000
U51 Admission status on psychiatric patients	0.545	0.455	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.545	0.455	0.000
I08 Multiple valve diseases	0.545	0.455	0.000
L25 Unspecified contact dermatitis	0.544	0.456	0.000
G96 Other disorders of central nervous system	0.544	0.456	0.000
W08 Fall involving other furniture	0.543	0.457	0.000
I65.3 Occlusion and stenosis of multiple and bilateral precerebral arteries	0.543	0.457	0.000
I88.9 Nonspecific lymphadenitis, unspecified	0.543	0.457	0.000
I78 Diseases of capillaries	0.543	0.457	0.000
G82 Paraplegia and tetraplegia	0.543	0.457	0.000
I69.3 Sequelae of cerebral infarction	0.542	0.458	0.000
I87.8 Other specified disorders of veins	0.541	0.459	0.000
Q60-Q64 Congenital malformations of the urinary system	0.541	0.459	0.000
V49.8 Car occupant [any] injured in other specified transport accidents	0.540	0.459	0.000
V49.6 Unspecified car occupant injured in collision with other and unspecified motor vehicles in traffic accident	0.540	0.459	0.000
V49.3 Car occupant [any] injured in unspecified nontraffic accident	0.540	0.459	0.000
V49.2 Unspecified car occupant injured in collision with other and unspecified motor vehicles in nontraffic accident	0.540	0.459	0.000
V49.1 Passenger injured in collision with other and unspecified motor vehicles in nontraffic accident	0.540	0.459	0.000
V49.0 Driver injured in collision with other and unspecified motor vehicles in nontraffic accident	0.540	0.459	0.000
L30.8 Other specified dermatitis	0.540	0.460	0.000
G30.1 Alzheimer's disease with late onset	0.540	0.460	0.000
F18 Mental and behavioural disorders due to use of volatile solvents	0.539	0.461	0.000
F16 Mental and behavioural disorders due to use of hallucinogens	0.539	0.461	0.000
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.539	0.461	0.000
F14 Mental and behavioural disorders due to use of cocaine	0.539	0.461	0.000
F13 Mental and behavioural disorders due to use of sedatives or hypnotics	0.539	0.461	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.538	0.462	0.000
W06.0 Home	0.538	0.462	0.000
F09 Unspecified organic or symptomatic mental disorder	0.537	0.463	0.000
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.537	0.463	0.000
E06.5 Other chronic thyroiditis	0.536	0.463	0.000
E06.4 Drug-induced thyroiditis	0.536	0.463	0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.536	0.463	0.000
E06.1 Subacute thyroiditis	0.536	0.463	0.000
E06.0 Acute thyroiditis	0.536	0.463	0.000
X45 Accidental poisoning by and exposure to alcohol	0.536	0.464	0.000
E73.8 Other lactose intolerance	0.536	0.464	0.000
E73.1 Secondary lactase deficiency	0.536	0.464	0.000
E73.0 Congenital lactase deficiency	0.536	0.464	0.000
G95 Other diseases of spinal cord	0.536	0.464	0.000
E44 Protein-energy malnutrition of moderate and mild degree	0.534	0.466	0.000
E45 Retarded development following protein-energy malnutrition	0.534	0.466	0.000
E43 Unspecified severe protein-energy malnutrition	0.534	0.466	0.000
E42 Marasmic kwashiorkor	0.534	0.466	0.000
E41 Nutritional marasmus	0.534	0.466	0.000
E40 Kwashiorkor	0.534	0.466	0.000
I65.1 Occlusion and stenosis of basilar artery	0.534	0.466	0.000
Q24.6 Congenital heart block	0.533	0.467	0.000
Q24.5 Malformation of coronary vessels	0.533	0.467	0.000
Q24.4 Congenital subaortic stenosis	0.533	0.467	0.000
Q24.3 Pulmonary infundibular stenosis	0.533	0.467	0.000
Q24.2 Cor triatriatum	0.533	0.467	0.000
Q24.1 Levocardia	0.533	0.467	0.000
Q24.0 Dextrocardia	0.533	0.467	0.000
I88.8 Other nonspecific lymphadenitis	0.533	0.467	0.000
I88.1 Chronic lymphadenitis, except mesenteric	0.533	0.467	0.000
G25.6 Drug-induced tics and other tics of organic origin	0.533	0.467	0.000
G25.5 Other chorea	0.533	0.467	0.000
G25.4 Drug-induced chorea	0.533	0.467	0.000
G25.2 Other specified forms of tremor	0.533	0.467	0.000
G25.1 Drug-induced tremor	0.533	0.467	0.000
E03.8 Other specified hypothyroidism	0.531	0.469	0.000
I61.4 Intracerebral haemorrhage in cerebellum	0.531	0.469	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.530	0.469	0.000
Y45.4 Antirheumatics	0.530	0.469	0.000
X51 Travel and motion	0.530	0.470	0.000
W00 Fall on same level involving ice and snow	0.530	0.470	0.000
I07.1 Tricuspid insufficiency	0.529	0.471	0.000
E89.3 Postprocedural hypopituitarism	0.528	0.471	0.000
V16 Pedal cyclist injured in collision with other nonmotor vehicle	0.528	0.472	0.000
V15 Pedal cyclist injured in collision with railway train or railway vehicle	0.528	0.472	0.000
V14 Pedal cyclist injured in collision with heavy transport vehicle or bus	0.528	0.472	0.000
V13 Pedal cyclist injured in collision with car, pick-up truck or van	0.528	0.472	0.000
V12 Pedal cyclist injured in collision with two- or three-wheeled motor vehicle	0.528	0.472	0.000
V11 Pedal cyclist injured in collision with other pedal cycle	0.528	0.472	0.000
V10 Pedal cyclist injured in collision with pedestrian or animal	0.528	0.472	0.000
Q86 Congenital malformation syndromes due to known exogenous causes, not elsewhere classified	0.526	0.474	0.000
Q84 Other congenital malformations of integument	0.526	0.474	0.000
Q81 Epidermolysis bullosa	0.526	0.474	0.000
Q80 Congenital ichthyosis	0.526	0.474	0.000
U50 Level of care administered to neonates	0.525	0.475	0.000
U07 Emergency use of U07	0.525	0.475	0.000
U06 Emergency use of U06	0.525	0.475	0.000
U04 Severe acute respiratory syndrome [SARS]	0.525	0.475	0.000
U52 First in a series of a regular day/night admissions	0.525	0.475	0.000
U80.0 Penicillin resistant agent	0.525	0.475	0.000
I89.9 Non-infective disorder of lymphatic vessels and lymph nodes, unspecified	0.524	0.475	0.000
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.524	0.475	0.000
I89.1 Lymphangitis	0.524	0.476	0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.524	0.476	0.000
V44 Car occupant injured in collision with heavy transport vehicle or bus	0.524	0.476	0.000
U84 Resistance to other antimicrobial drugs	0.523	0.477	0.000
U83 Resistance to other antibiotics	0.523	0.477	0.000
U82 Resistance to betalactam antibiotics	0.523	0.477	0.000
U85 Resistance to antineoplastic drugs	0.523	0.477	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.523	0.477	0.000
F52 Sexual dysfunction, not caused by organic disorder or disease	0.523	0.477	0.000
V17 Pedal cyclist injured in collision with fixed or stationary object	0.522	0.477	0.000
X78 Intentional self-harm by sharp object	0.522	0.478	0.000
I70.9 Generalised and unspecified atherosclerosis	0.522	0.478	0.000
I70.8 Atherosclerosis of other arteries	0.522	0.478	0.000
F10.9 Unspecified mental and behavioural disorder	0.522	0.478	0.000
I68 Cerebrovascular disorders in diseases classified elsewhere	0.521	0.479	0.000
I72.6 Aneurysm and dissection of vertebral artery	0.521	0.479	0.000
I72.5 Aneurysm and dissection of other precerebral arteries	0.521	0.479	0.000
I72.2 Aneurysm of renal artery	0.521	0.479	0.000
I72.1 Aneurysm of artery of upper extremity	0.521	0.479	0.000
L73 Other follicular disorders	0.521	0.479	0.000
G25.0 Essential tremor	0.521	0.479	0.000
L20.9 Atopic dermatitis, unspecified	0.519	0.481	0.000
U81 Agent resistant to vancomycin and related antibiotics	0.518	0.482	0.000
G01 Meningitis in bacterial diseases classified elsewhere	0.518	0.482	0.000
Y48.3 Local anaesthetics	0.517	0.483	0.000
I71.9 Aortic aneurysm of unspecified site, without mention of rupture	0.517	0.483	0.000
L68 Hypertrichosis	0.515	0.485	0.000
G30.9 Alzheimer's disease, unspecified	0.515	0.485	0.000
L12 Pemphigoid	0.515	0.485	0.000
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.515	0.485	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.515	0.485	0.000
I71.3 Abdominal aortic aneurysm, ruptured	0.514	0.485	0.000
V19 Pedal cyclist injured in other and unspecified transport accidents	0.512	0.487	0.000
I72.9 Aneurysm of unspecified site	0.511	0.488	0.000
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.511	0.488	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.511	0.489	0.000
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.511	0.489	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations